Japan drug approvals

iPharmaCenter

Putting patients at center

Home
COVID-19
News
Conferences
Healthcare Policies & Systems
Regional News
Patient info
More

Use tab to navigate through the menu items.

All Posts
TraditionalHealthcare
Healthcare Systems
News
Conferences
Know your disease
COVID
Japan drug approvals
USA Pharma News | Healthcare News
Europe Pharma News
Japan drug approvals
Australia Pharma & Healthcare News
Canada Pharma and Healthcare News
Asia | Pharma | Healthcare News
Indication News

Search

Japan Pharma and Healthcare News | Blogs | iPharmaCenter

ipharmaservices

Jan 31

Japan Pharma and Healthcare News | Blogs | iPharmaCenter

0

Novartis and BeiGene collaboration strengthens the Swiss drugmaker's oncology portfolio

ipharmaservices

Jan 12, 2021

Novartis and BeiGene collaboration strengthens the Swiss drugmaker's oncology portfolio

0

ipharmaservices

Sep 25, 2020

Gilead received the approval of Jyseleca from the European and Japan regulatory authorities for RA

0

AZ received one more approval in Japan, received approval of Imfinzi for SCLC

ipharmaservices

Aug 22, 2020

AZ received one more approval in Japan, received approval of Imfinzi for SCLC

0

ipharmaservices

Aug 17, 2020

JAPAN HEALTHCARE SYSTEM

0

ipharmaservices

Jul 9, 2020

Eisai's Dayvigo was approved in Japan and Hong Kong for insomnia

0

ipharmaservices

Mar 29, 2020

AstraZeneca's Lokelma approved in Japan

0

Please feel free to share your thoughts and comments. If you have questions, please comment, and we will try to get back with answers. If you liked the content, please share it on your network.

For any further updates, contact us at ipharmaservices@gmail.com